Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-6512
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies ; volume:12 ; number:1 ; day:18 ; month:8 ; year:2021 ; pages:1-11 ; date:12.2021
Stem cell research & therapy ; 12, Heft 1 (18.8.2021), 1-11, 12.2021
- Urheber
-
Li, Deng-Yuan
Li, Ru-Fang
Sun, Dan-Xiong
Pu, Dan-Dan
Zhang, Yun-Hui
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13287-021-02496-2
- URN
-
urn:nbn:de:101:1-2021110606185168350643
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Deng-Yuan
- Li, Ru-Fang
- Sun, Dan-Xiong
- Pu, Dan-Dan
- Zhang, Yun-Hui
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
Stem cell-based therapy for pulmonary fibrosis
Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats
Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis
Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
Stem cell-based therapy for pulmonary fibrosis
Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats
Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis
Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis
Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis
Stem cell-based therapy for pulmonary fibrosis
Targeted migration of bone marrow mesenchymal stem cells inhibits silica-induced pulmonary fibrosis in rats
Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
The role of epithelial-mesenchymal transition in pulmonary fibrosis: lessons from idiopathic pulmonary fibrosis and COVID-19
Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition